Sinan Yavuz

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Bone marrow necrosis: Clinicopathologic analysis of 20 cases and review of the literature

Semra Paydaş, Melek Ergin, Fikri Başlamıslı et al. · American Journal of Hematology · 2002 · 145 citations · Full text

PRAME mRNA levels in cases with acute leukemia: Clinical importance and future prospects

Semra Paydaş, Kahraman Tanrıverdi, Sinan Yavuz et al. · American Journal of Hematology · 2005 · 71 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Pathology +19

Survivin and aven: two distinct antiapoptotic signals in acute leukemias

Semra Paydaş, Sinan Yavuz, Umut Dişel et al. · Annals of Oncology · 2003 · 51 citations · Full text

Tumor Biology, Medicine, Pharmacology +4

Effect of colchicine on cyclosporine nephrotoxicity, reduction of TGF-beta overexpression, apoptosis, and oxidative damage: an experimental animal study

Umut Dişel, Saime Paydaş, Ayşe Doğan et al. · Transplantation Proceedings · 2004 · 48 citations

Inflammation, Medicine, Lipid Peroxidation +10